MedTrace Logo

Single Low-Dose of Supplement Amino Acid

NCT01540773 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2018-10-22

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to confirm the results of a prior study that demonstrated pills containing two amino acids which are in foods increased growth hormone and insulin-like growth factor-1.

Conditions

  • Growth Hormone
  • Amino Acid

Interventions

DRUG

Amino acid supplement

An orally administered supplement of the proprietary amino acid derivative

DRUG

Placebo

A non-active orally administered supplement of the proprietary amino acid derivative

Sponsors & Collaborators

  • Pennington Biomedical Research Center

    lead OTHER

Principal Investigators

  • Frank Greenway, MD · Pennington Biomedical Research Center

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2011-12-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01540773 on ClinicalTrials.gov